Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pain, Postoperative 32Breast Neoplasms 25Lung Neoplasms 12Pain 11Agnosia 11Leiomyoma 7Pancreatic Neoplasms 5Neoplasms 5Prostatic Neoplasms 4Colorectal Neoplasms 4Rectal Neoplasms 3Neuroma 3Neuralgia 3Hot Flashes 3Colonic Neoplasms 3Thyroid Nodule 2Thyroid Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphedema 2Liver Neoplasms 2Kidney Neoplasms 2Ileus 2Hyperparathyroidism 2Goiter 2Digestive System Diseases 2Chronic Pain 2Breast Cancer Female 2Brain Neoplasms 2Adenomyosis 2Abdominal Cancer 2

Interventions

Gemcitabine 157Cisplatin 117pembrolizumab 81Cystectomy 46Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Docetaxel 39atezolizumab 33Magnetic Resonance Spectroscopy 33Radiotherapy 31durvalumab 30avelumab 26BCG Vaccine 26Specimen Handling 25Cystoscopy 24enfortumab vedotin 23Doxorubicin 23Fluorouracil 20Methotrexate 17Vinblastine 16Standard of Care 15Ipilimumab 14Filgrastim 145-aminolevulinic acid hexyl ester 14Transurethral Resection of Bladder 13Surgical Procedures, Operative 13Sunitinib 13Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Bupivacaine × Clear all
NCT02534623 2015-08-27

Postoperative Quality of Recovery After Transurethral Resection of the Bladder

General Hospital Zadar

Phase NA Unknown
70 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡